Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
DexCom Inc (DXCM)  
$110.57 6.07 (5.2%) as of 4:30 Mon 6/24


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 389,580,000
Market Cap: 43.08(B)
Last Volume: 4,690,332 Avg Vol: 1,930,532
52 Week Range: $75.49 - $140.45
Level I Sector: Health Care
Level II Sector: Health Services
Level III Sector: Medical Instruments & Supplies

Member Indexes:

    NASDAQ COMPOSITE     NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  487
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   DexCom is a medical device company primarily focused on the design, development and commercialization of continuous glucose monitoring (CGM) systems. Co.'s product candidates include Dexcom G7®, which is designed with the goal of carrying forward many of the same features as Co.'s G6 CGM system and adding several new or improved features. Co.'s products include: DexCom G6® integrated Continuous Glucose Monitoring System (G6), which is a type of CGM system to be used as part of an integrated system with other medical devices and electronic interfaces; and DexCom Share®, which transmit glucose information to the cloud and then to apps on the mobile devices of up to five designated recipients.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 71,005 274,979 309,595 581,627
Total Sell Value $9,585,020 $36,298,507 $40,264,880 $70,726,419
Total People Sold 8 10 14 16
Total Sell Transactions 13 27 50 85
End Date 2024-03-24 2023-12-22 2023-06-23 2022-06-23

   
Records found: 2309
  Page 30 of 93  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 AS $0.00 $0 D/D (17,386) 46,534     -
   Moy Jeffrey SVP, Operations   •       –      –    2018-09-10 4 AS $143.76 $660,411 D/D (4,594) 63,920     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2018-09-10 4 S $143.76 $788,210 D/D (5,483) 116,974     -
   Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr   •       –      –    2018-09-10 4 AS $143.35 $340,825 D/D (2,372) 31,308     -
   Abbey Donald EVP, Quality & Regulatory Afrs   •       –      –    2018-09-10 4 S $143.76 $331,068 D/D (2,303) 98,639     -
   Blackford Quentin S. EVP, CFO, PFO & PAO   •       –      –    2018-09-10 4 S $143.76 $1,027,706 D/D (7,149) 95,571     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-09-10 4 S $143.76 $788,210 D/D (5,483) 66,804     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-09-10 4 AS $142.31 $3,661,573 D/D (25,495) 320,837     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-09-10 4 OE $4.58 $51,117 D/D 11,161 346,332     -
   Balo Andrew K EVP, Reg. Strategy, Clinical   •       –      –    2018-09-10 4 S $143.76 $803,160 D/D (5,587) 93,105     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-08-31 4 A $0.00 $0 I/I 20,830 20,830     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-08-31 4 D $0.00 $0 D/D (20,830) 72,287     -
   Altman Steven R Director   –       •      –    2018-08-24 4 S $136.47 $682,359 I/I (5,000) 0     -
   Foletta Mark G Director   –       •      –    2018-08-24 4 S $137.50 $137,503 I/I (1,000) 17,095     -
   Leach Jacob Steven SVP, Research & Development   •       –      –    2018-08-24 4 S $138.32 $2,846,155 D/D (20,577) 98,878     -
   Leach Jacob Steven SVP, Research & Development   •       –      –    2018-08-24 4 OE $3.19 $92,941 D/D 20,577 108,878     -
   Pacelli Steven Robert EVP, Strategy & Corp. Dev.   •       –      –    2018-08-23 4 AS $139.66 $435,843 D/D (3,114) 122,457     -
   Doubleday Richard EVP, Chief Commercial Officer   •       –      –    2018-08-23 4 AS $139.73 $361,833 I/I (2,584) 0     -
   Ace Heather S SVP Human Resources   •       –      –    2018-08-23 4 D $141.59 $433,412 D/D (3,061) 71,171     -
   Balo Andrew K EVP, Reg. Strategy, Clinical   •       –      –    2018-08-14 4 AS $124.16 $621,253 D/D (5,000) 98,567     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-08-13 4 AS $122.41 $1,375,211 D/D (11,161) 335,171     -
   Sayer Kevin R President, CEO & Chairman   •       •      –    2018-08-13 4 OE $4.58 $51,117 D/D 11,161 346,332     -
   Murphy Patrick Michael VP, Legal Aff & Chf Compl Ofcr   •       –      –    2018-08-10 4 AS $121.94 $1,552,310 D/D (12,500) 33,680     -
   Augustinos Nicholas Director   –       •      –    2018-08-06 4 S $121.77 $393,301 I/I (3,230) 14,362     -
   Augustinos Nicholas Director   –       •      –    2018-08-06 4 S $120.91 $1,099,080 D/D (9,070) 7,802     -

  2309 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 30 of 93
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed